During the past decade, Kardiologie am Tibarg conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kardiologie am Tibarg" are "Hypercholesterolemia" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Diseases" (1 trials) and "Dyslipidemic" (1 trials). Many other conditions were trialed in "Kardiologie am Tibarg" in a lesser frequency.

Most popular intervention types in "Kardiologie am Tibarg" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bempedoic acid and/or its fixed-dose combination with ezetimibe" (1 trials), "Edoxaban" (1 trials) and "Non-interventional" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kardiologie am Tibarg" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kardiologie am Tibarg". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kardiologie am Tibarg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kardiologie am Tibarg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".